Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

HPV-prevalence in elderly women in Denmark

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Histological outcomes in HPV-screened elderly women in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Nonalcoholic Fatty Liver Disease Impairs the Liver-Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Driving following defibrillator implantation: development and pilot results from a nationwide questionnaire

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Cervical screening in Denmark - a success followed by stagnation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Berit Andersen
  • Birgitte Schütt Christensen
  • Jette Christensen
  • Dorthe Ejersbo
  • Hanne Nørgaard Heje
  • Kirsten Marie Jochumsen
  • Tonje Johansen
  • Lise Grupe Larsen
  • Elsebeth Lynge
  • Reza Serizawa
  • Petra Hall Viborg
  • Marianne Waldstrøm
Vis graf over relationer

AIM: In countries like Denmark, cervical cancer incidence is at present relatively high in elderly women, while routine screening stops at age 65 years. On this background, all women aged 69 and above were invited to human papillomavirus (HPV)-screening in Denmark in 2017.

METHODS: Women were identified from the Central Population Register and personally invited by digital or ordinary mail to have a screening sample taken by their general practitioner. In four regions, samples were tested for high risk (HPV) with the cobas 4800® HPV-assay, and in the last region with the BD Onclarity® HPV-assay. Participation rate, prevalence of high risk HPV, and proportion of positive samples with HPV16, HPV18, and other high risk HPV-types were tabulated by 5-year age-groups.

RESULTS: 455,612 women were invited, and 30.2% (95 confidence interval (CI) 30.0-30.3) participated. Average age of participants was 74.6 years. Overall, 4.3% (95% CI 4.1-4.4) of participants were HPV-positive, of whom 24% had HPV 16/18. HPV-prevalence decreased slightly from 4.5% in women aged 69-73 years to 3.1% in women aged 84-88 years, but was 5.2% in the very small group of participants aged 89+ years.

CONCLUSION: Invitation to HPV-screening was well received by elderly women. The HPV-prevalence decreased slightly with increasing age. No rebound of HPV-prevalence after menopause was found when our data were combined with previously published Danish data from younger women. The presently relatively high cervical cancer incidence in elderly women was not reflected in the HPV-prevalence.

TidsskriftGynecologic Oncology
Udgave nummer1
Sider (fra-til)118-123
Antal sider6
StatusUdgivet - jul. 2019

Bibliografisk note

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

ID: 57194004